• Primary hemostasis action

• 100% biocompatible and bioabsorbable

• Chemically developed composition with fast-absorbing small-chain polysaccharide and large particles 

• Has a dehydrating effect

• It has a primary hemostasis time between 1 to 2 minutes

• Reduces the time of the agglutination clotting process with or without normal clotting factors

• Supports the effects of the coagulation cascade on factors VIII, IX, XI and XII 

• Its application allows visual monitoring

• Soluble in water, facilitating removal at the end of the surgical procedure

• Little interference in imaging tests 

• ANVISA Records: 80030810120 / 80030810122

​

​

Available in four versions: 

​

• Bleed STP: small-chain polysaccharide with rapid absorption by the body; within 48 hours it is eliminated by the body. Presented in the powder version, it is easily applied through the bellows and cannula that come with the product.    

​ ​

• Bleed STP+: slower absorbing version; elimination by the body within 7 days.  Indicated to meet the demands of various professionals, promoting continuous improvement in primary hemostasis processes. In the powder version, it is easily applied through the bellows and cannula that come with the product.

​ ​

• Bleed STP+ Gel: for hard-to-apply areas. Its consistency allows for fluid application, but without product flow. 

​ ​

• Bleed STP+ Sponge: the product is indicated for surgical procedures and for dressings external to the body, when a large amount of material is needed in a small area. These include specialties such as otolaryngology and oral and maxillofacial, areas of the peritoneum and others that have greater blood flow.